
Backing AI-Driven Science to Tackle Chronic Illnesses in an Aging World


Our Mission
Drive disruptive healthcare innovation by supporting impact-driven founders with financial, intellectual, and social capital.
Our Vision
Launch 3 institutional-grade microfunds by 2030, to back 60 startups delivering transformative patient impact and strong investor returns.
Values
Impact, Inspiration, Involvement & Integrity.

Rise in Longevity
Life expectancy rose from 77 to 82 years, with the 65+ population set to double by 2040.

Rise in Chronic Diseases
Heart and brain diseases are the #1 killers, with innovation costs 30% lower compared to other diseases.

Rise in AI
AI delivers 50% faster timelines, doubles trial success, and cuts implementation costs.

Rise in Acquisitions
Acquisitions are 5× higher than historical averages, with 60% happening in pre-clinical stages and 80% of unicorn drugs coming from external pipelines.
Investment Approach
We invest at the intersection of 4 mega trends.
"Our advisors are all part of a Prime Network of Credible Experts to Strengthen Our Conviction, Open Doors, and Support Founders."
About Us
Sila B Health Ventures is a boutique firm investing in early-stage Bio-Pharma startups driving therapeutic innovation at the crossroads of chronic disease and aging. We manage micro-funds of $5M–$20M, primarily at pre-seed and seed stages, providing $75K–$150K checks along with strategic advisory, execution tools, and access to a robust network of investors and domain experts. We collaborate with founders in Cardiology, Metabolic Health, Neurology, and Psychiatry, as well as individual and institutional investors, to create meaningful impact for patients.

Value Added to Founders

Financial Capital
We offer tailored checks from $75K to $250K to support breakthrough innovations.

Social Capital
Our network links founders with top industry players, advisors, and collaborators.

Intellectual Capital
We provide guidance across development, clinical stages, and offer coaching, AI tools, and mentoring to overcome early-stage hurdles.
Take the Next Steps

The information herein is strictly confidential and is intended for authorized recipients only. The content of this presentation is shown for information purposes only and is not intended as investment advice or an offer or solicitation with respect to the purchase or sale of any security.
The strategy presented herein represents the strategy of the General Partner of the Fund as of the risky, may vary at the discretion of the General Partner. Recipients should not assume that any companies identified in this presentation are or will be investments held by the Fund.
There is no guarantee that any investment objective will be achieved. Past performance is not indicative of future results. Actual results may differ materially from those expressed or implied. Any projected returns presented herein are shown for illustrative purposes only. There can be no guarantee the Fund will achieve these results. Venture investing is risky, and you could lose some or all of your investment.
The information contained herein constitutes forward-looking statements. We assume no obligation to update, and you should not unduly rely on such statements.